GO:1901566 | organonitrogen compound biosynthetic process | 16.14% (36/223) | 2.82 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 13.45% (30/223) | 2.63 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 22.42% (50/223) | 1.78 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 21.97% (49/223) | 1.68 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 7.62% (17/223) | 3.29 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 9.42% (21/223) | 2.87 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 17.94% (40/223) | 1.81 | 0.0 | 0.0 |
GO:0005840 | ribosome | 8.97% (20/223) | 2.86 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 9.42% (21/223) | 2.77 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 15.7% (35/223) | 1.98 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 9.42% (21/223) | 2.73 | 0.0 | 0.0 |
GO:0006412 | translation | 8.97% (20/223) | 2.81 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 17.94% (40/223) | 1.75 | 0.0 | 0.0 |
GO:0043603 | cellular amide metabolic process | 9.42% (21/223) | 2.68 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 18.83% (42/223) | 1.69 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 8.97% (20/223) | 2.77 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 8.97% (20/223) | 2.71 | 0.0 | 0.0 |
GO:0006520 | cellular amino acid metabolic process | 7.17% (16/223) | 3.07 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 8.97% (20/223) | 2.47 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 8.97% (20/223) | 2.47 | 0.0 | 0.0 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.48% (10/223) | 3.75 | 0.0 | 0.0 |
GO:1901293 | nucleoside phosphate biosynthetic process | 4.93% (11/223) | 3.51 | 0.0 | 0.0 |
GO:0009165 | nucleotide biosynthetic process | 4.93% (11/223) | 3.51 | 0.0 | 0.0 |
GO:0043436 | oxoacid metabolic process | 7.17% (16/223) | 2.72 | 0.0 | 0.0 |
GO:0019752 | carboxylic acid metabolic process | 7.17% (16/223) | 2.72 | 0.0 | 0.0 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 5.83% (13/223) | 3.11 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 24.66% (55/223) | 1.19 | 0.0 | 0.0 |
GO:0006082 | organic acid metabolic process | 7.17% (16/223) | 2.69 | 0.0 | 0.0 |
GO:0072522 | purine-containing compound biosynthetic process | 4.04% (9/223) | 3.91 | 0.0 | 0.0 |
GO:0043039 | tRNA aminoacylation | 4.48% (10/223) | 3.6 | 0.0 | 0.0 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4.48% (10/223) | 3.6 | 0.0 | 0.0 |
GO:0043038 | amino acid activation | 4.48% (10/223) | 3.6 | 0.0 | 0.0 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 4.48% (10/223) | 3.6 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 25.56% (57/223) | 1.13 | 0.0 | 0.0 |
GO:0009117 | nucleotide metabolic process | 4.93% (11/223) | 3.1 | 0.0 | 0.0 |
GO:0006164 | purine nucleotide biosynthetic process | 3.59% (8/223) | 3.81 | 0.0 | 0.0 |
GO:0006753 | nucleoside phosphate metabolic process | 4.93% (11/223) | 3.07 | 0.0 | 1e-06 |
GO:0072521 | purine-containing compound metabolic process | 4.04% (9/223) | 3.45 | 0.0 | 1e-06 |
GO:0044238 | primary metabolic process | 25.11% (56/223) | 1.02 | 0.0 | 1e-06 |
GO:0140101 | catalytic activity, acting on a tRNA | 4.48% (10/223) | 3.0 | 0.0 | 4e-06 |
GO:0046390 | ribose phosphate biosynthetic process | 3.14% (7/223) | 3.77 | 0.0 | 4e-06 |
GO:0009260 | ribonucleotide biosynthetic process | 3.14% (7/223) | 3.77 | 0.0 | 4e-06 |
GO:0009152 | purine ribonucleotide biosynthetic process | 3.14% (7/223) | 3.77 | 0.0 | 4e-06 |
GO:0071704 | organic substance metabolic process | 25.56% (57/223) | 0.95 | 0.0 | 4e-06 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.79% (4/223) | 5.13 | 1e-06 | 7e-06 |
GO:0006163 | purine nucleotide metabolic process | 3.59% (8/223) | 3.33 | 1e-06 | 7e-06 |
GO:0090407 | organophosphate biosynthetic process | 4.93% (11/223) | 2.64 | 1e-06 | 1.1e-05 |
GO:0003723 | RNA binding | 6.28% (14/223) | 2.23 | 1e-06 | 1.4e-05 |
GO:0140098 | catalytic activity, acting on RNA | 5.38% (12/223) | 2.43 | 2e-06 | 1.7e-05 |
GO:0006399 | tRNA metabolic process | 4.48% (10/223) | 2.73 | 2e-06 | 1.8e-05 |
GO:0003743 | translation initiation factor activity | 2.69% (6/223) | 3.81 | 2e-06 | 1.9e-05 |
GO:0034645 | cellular macromolecule biosynthetic process | 9.87% (22/223) | 1.61 | 3e-06 | 2.5e-05 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 2.69% (6/223) | 3.72 | 3e-06 | 2.8e-05 |
GO:0009259 | ribonucleotide metabolic process | 3.14% (7/223) | 3.24 | 6e-06 | 4.8e-05 |
GO:0019693 | ribose phosphate metabolic process | 3.14% (7/223) | 3.24 | 6e-06 | 4.8e-05 |
GO:0009150 | purine ribonucleotide metabolic process | 3.14% (7/223) | 3.24 | 6e-06 | 4.8e-05 |
GO:0005737 | cytoplasm | 3.59% (8/223) | 2.92 | 7e-06 | 6e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 13.0% (29/223) | 1.27 | 9e-06 | 6.9e-05 |
GO:0008152 | metabolic process | 29.15% (65/223) | 0.73 | 1.2e-05 | 9.2e-05 |
GO:1901360 | organic cyclic compound metabolic process | 13.0% (29/223) | 1.24 | 1.3e-05 | 0.0001 |
GO:0009059 | macromolecule biosynthetic process | 9.87% (22/223) | 1.46 | 1.5e-05 | 0.000115 |
GO:0034660 | ncRNA metabolic process | 4.48% (10/223) | 2.35 | 2.2e-05 | 0.00017 |
GO:0046483 | heterocycle metabolic process | 12.56% (28/223) | 1.22 | 2.4e-05 | 0.000177 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0006754 | ATP biosynthetic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0015986 | ATP synthesis coupled proton transport | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0015985 | energy coupled proton transport, down electrochemical gradient | 2.24% (5/223) | 3.65 | 2.9e-05 | 0.000177 |
GO:0045182 | translation regulator activity | 2.69% (6/223) | 3.26 | 2.5e-05 | 0.000181 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2.69% (6/223) | 3.26 | 2.5e-05 | 0.000181 |
GO:0008135 | translation factor activity, RNA binding | 2.69% (6/223) | 3.26 | 2.5e-05 | 0.000181 |
GO:0009987 | cellular process | 31.39% (70/223) | 0.65 | 2.7e-05 | 0.000188 |
GO:0019637 | organophosphate metabolic process | 4.93% (11/223) | 2.15 | 3.3e-05 | 0.000197 |
GO:0009141 | nucleoside triphosphate metabolic process | 2.24% (5/223) | 3.55 | 4.3e-05 | 0.000253 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.66% (26/223) | 1.2 | 5.5e-05 | 0.00032 |
GO:1901137 | carbohydrate derivative biosynthetic process | 3.14% (7/223) | 2.77 | 5.7e-05 | 0.000331 |
GO:0017076 | purine nucleotide binding | 13.0% (29/223) | 1.09 | 8.3e-05 | 0.000476 |
GO:0097159 | organic cyclic compound binding | 21.97% (49/223) | 0.77 | 9.8e-05 | 0.000546 |
GO:1901363 | heterocyclic compound binding | 21.97% (49/223) | 0.77 | 9.8e-05 | 0.000546 |
GO:0044267 | cellular protein metabolic process | 9.42% (21/223) | 1.28 | 0.00014 | 0.00077 |
GO:0035639 | purine ribonucleoside triphosphate binding | 12.56% (28/223) | 1.07 | 0.000142 | 0.000772 |
GO:1901135 | carbohydrate derivative metabolic process | 3.59% (8/223) | 2.35 | 0.000147 | 0.000791 |
GO:0043229 | intracellular organelle | 9.42% (21/223) | 1.27 | 0.000161 | 0.000844 |
GO:0043226 | organelle | 9.42% (21/223) | 1.27 | 0.000161 | 0.000844 |
GO:0032555 | purine ribonucleotide binding | 12.56% (28/223) | 1.05 | 0.00017 | 0.000883 |
GO:0019867 | outer membrane | 1.35% (3/223) | 4.4 | 0.000219 | 0.001125 |
GO:0032553 | ribonucleotide binding | 12.56% (28/223) | 1.02 | 0.000267 | 0.001358 |
GO:0097367 | carbohydrate derivative binding | 12.56% (28/223) | 1.01 | 0.000276 | 0.00139 |
GO:0019438 | aromatic compound biosynthetic process | 7.17% (16/223) | 1.43 | 0.000279 | 0.001391 |
GO:0046034 | ATP metabolic process | 2.24% (5/223) | 3.0 | 0.000318 | 0.001551 |
GO:0008652 | cellular amino acid biosynthetic process | 2.24% (5/223) | 3.0 | 0.000318 | 0.001551 |
GO:0003674 | molecular_function | 49.33% (110/223) | 0.37 | 0.000377 | 0.001818 |
GO:1901362 | organic cyclic compound biosynthetic process | 7.17% (16/223) | 1.36 | 0.000473 | 0.002259 |
GO:0031966 | mitochondrial membrane | 1.79% (4/223) | 3.33 | 0.000513 | 0.002425 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0004749 | ribose phosphate diphosphokinase activity | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.9% (2/223) | 5.13 | 0.000808 | 0.003408 |
GO:0019538 | protein metabolic process | 9.87% (22/223) | 1.07 | 0.000741 | 0.003434 |
GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) | 1.35% (3/223) | 3.91 | 0.000734 | 0.003435 |
GO:0110165 | cellular anatomical entity | 17.49% (39/223) | 0.75 | 0.00076 | 0.003485 |
GO:0043170 | macromolecule metabolic process | 16.14% (36/223) | 0.78 | 0.000837 | 0.003496 |
GO:0046394 | carboxylic acid biosynthetic process | 2.24% (5/223) | 2.7 | 0.000868 | 0.003565 |
GO:0016053 | organic acid biosynthetic process | 2.24% (5/223) | 2.7 | 0.000868 | 0.003565 |
GO:0018130 | heterocycle biosynthetic process | 6.73% (15/223) | 1.33 | 0.000894 | 0.003639 |
GO:1902600 | proton transmembrane transport | 2.24% (5/223) | 2.65 | 0.001033 | 0.004167 |
GO:0005575 | cellular_component | 20.63% (46/223) | 0.65 | 0.001056 | 0.004225 |
GO:0017144 | drug metabolic process | 2.24% (5/223) | 2.6 | 0.001219 | 0.004836 |
GO:1901265 | nucleoside phosphate binding | 13.0% (29/223) | 0.85 | 0.001277 | 0.004982 |
GO:0000166 | nucleotide binding | 13.0% (29/223) | 0.85 | 0.001277 | 0.004982 |
GO:0034220 | ion transmembrane transport | 2.69% (6/223) | 2.26 | 0.001428 | 0.005522 |
GO:0015672 | monovalent inorganic cation transport | 2.24% (5/223) | 2.5 | 0.001666 | 0.00639 |
GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o) | 1.35% (3/223) | 3.55 | 0.001689 | 0.006425 |
GO:0030554 | adenyl nucleotide binding | 9.87% (22/223) | 0.98 | 0.001747 | 0.006593 |
GO:0044283 | small molecule biosynthetic process | 2.69% (6/223) | 2.1 | 0.002513 | 0.009408 |
GO:0098798 | mitochondrial protein complex | 1.79% (4/223) | 2.67 | 0.003134 | 0.011641 |
GO:0005524 | ATP binding | 9.42% (21/223) | 0.93 | 0.003217 | 0.011856 |
GO:0036094 | small molecule binding | 13.0% (29/223) | 0.76 | 0.003476 | 0.012708 |
GO:0032559 | adenyl ribonucleotide binding | 9.42% (21/223) | 0.91 | 0.003741 | 0.013572 |
GO:0005488 | binding | 28.25% (63/223) | 0.45 | 0.003797 | 0.013668 |
GO:0043168 | anion binding | 12.56% (28/223) | 0.76 | 0.00387 | 0.013825 |
GO:0005741 | mitochondrial outer membrane | 0.9% (2/223) | 4.13 | 0.00467 | 0.016188 |
GO:0031968 | organelle outer membrane | 0.9% (2/223) | 4.13 | 0.00467 | 0.016188 |
GO:0098805 | whole membrane | 0.9% (2/223) | 4.13 | 0.00467 | 0.016188 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 0.9% (2/223) | 4.13 | 0.00467 | 0.016188 |
GO:0000287 | magnesium ion binding | 1.35% (3/223) | 3.02 | 0.005284 | 0.018183 |
GO:0031090 | organelle membrane | 1.79% (4/223) | 2.43 | 0.00586 | 0.019588 |
GO:0098662 | inorganic cation transmembrane transport | 2.24% (5/223) | 2.1 | 0.005835 | 0.019645 |
GO:0098655 | cation transmembrane transport | 2.24% (5/223) | 2.1 | 0.005835 | 0.019645 |
GO:0098660 | inorganic ion transmembrane transport | 2.24% (5/223) | 2.1 | 0.005835 | 0.019645 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.38% (12/223) | 1.19 | 0.0065 | 0.021575 |
GO:1901605 | alpha-amino acid metabolic process | 1.79% (4/223) | 2.38 | 0.006728 | 0.022173 |
GO:0006839 | mitochondrial transport | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0016778 | diphosphotransferase activity | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0009116 | nucleoside metabolic process | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:1901657 | glycosyl compound metabolic process | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0009066 | aspartate family amino acid metabolic process | 0.9% (2/223) | 3.81 | 0.007637 | 0.023987 |
GO:0001883 | purine nucleoside binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0032561 | guanyl ribonucleotide binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0032550 | purine ribonucleoside binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0005525 | GTP binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0032549 | ribonucleoside binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0001882 | nucleoside binding | 3.14% (7/223) | 1.58 | 0.008631 | 0.025892 |
GO:0008144 | drug binding | 9.42% (21/223) | 0.81 | 0.008381 | 0.026147 |
GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain | 1.35% (3/223) | 2.72 | 0.009715 | 0.028958 |
GO:0019001 | guanyl nucleotide binding | 3.14% (7/223) | 1.51 | 0.011091 | 0.032646 |
GO:0015078 | proton transmembrane transporter activity | 1.79% (4/223) | 2.18 | 0.01104 | 0.0327 |
GO:0019843 | rRNA binding | 0.9% (2/223) | 3.55 | 0.011241 | 0.032881 |
GO:0098800 | inner mitochondrial membrane protein complex | 1.35% (3/223) | 2.63 | 0.011552 | 0.033372 |
GO:1901607 | alpha-amino acid biosynthetic process | 1.35% (3/223) | 2.63 | 0.011552 | 0.033372 |
GO:0008150 | biological_process | 34.98% (78/223) | 0.32 | 0.012341 | 0.035434 |
GO:0006811 | ion transport | 3.14% (7/223) | 1.43 | 0.014838 | 0.042342 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 1.79% (4/223) | 2.05 | 0.015229 | 0.043196 |
GO:0098588 | bounding membrane of organelle | 0.9% (2/223) | 3.33 | 0.015444 | 0.043541 |